The World Anti-Doping Agency (WADA) acknowledges today’s release, by the Board of UK Anti-Doping (UKAD), of a Report that summarizes the findings and recommendations made by an Independent Review into UKAD’s handling of intelligence in relation to a UK-based doctor, Dr. Mark Bonar.
The Independent Review was commissioned by the UKAD Board further to media reports claiming that Dr. Bonar had provided a number of British athletes with performance enhancing substances. The principal aim of the Review was to assess how UKAD had managed information passed to it by an athlete and whether proper procedures had been followed in regards to the handling of that intelligence.
“WADA has read the Report of UKAD’s Independent Review with interest, noting its findings and recommendations,” said Olivier Niggli, Director General. “We acknowledge the complexities of handling such cases; and that, in this case, UKAD admits to having missed opportunities to gather intelligence, secure evidence, and investigate Bonar,” Niggli continued. “We would however like to reiterate our support for UKAD that, over the years, has proven to be a valued partner to WADA and other anti-doping organizations around the world in protecting clean sport.”
WADA also takes note of the recommendations that came out of the Independent Review, which relate to Substantial Assistance; and, as recommended, will work with UKAD in relation to these recommendations.